Evidence map›Paper›PMID 32687503›Full record

ArticlePloS one2020

The presence of Merkel cell carcinoma polyomavirus is associated with a distinct phenotype in neoplastic Merkel cell carcinoma cells and their tissue microenvironment.

María-Dolores Mendoza, Carlos Santonja, Carmen Gonzalez-Vela, Angel Concha, Nicolás Iglesias Pena, Eva-Maria Andrés-Esteban, Jose Pedro Vaque, Laura Cereceda, Raquel Pajares, H Kutzner and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Macrophages in oncoviral infections: from immune regulators to therapeutic targets.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
  2. Review
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

María-Dolores MendozaDepartment of Dermatology, Fundación Jiménez Díaz, Madrid, Spain.
Carlos SantonjaDepartment of Pathology, Fundación Jiménez Díaz, Madrid, Spain.ORCID 0000-0002-1335-0339
Carmen Gonzalez-VelaDepartment of Pathology, HUMV, Santander, Spain.
Angel ConchaDepartment of Pathology, Estructura Organizativa de Xestión Integrada de A Coruña, Coruña, Spain.
Nicolás Iglesias PenaDepartment of Dermatology, Estructura Organizativa de Xestión Integrada de A Coruña, Coruña, Spain.ORCID 0000-0002-7282-5015
Eva-Maria Andrés-EstebanUniversidad Rey Juan Carlos, PBM.idiPAZ, Madrid, Spain.
Jose Pedro VaqueIDIVAL, Universidad de Cantabria, Santander, Spain.
Laura CerecedaDepartment of Pathology, Fundación Jiménez Díaz, Madrid, Spain.
Raquel PajaresDepartment of Pathology, Fundación Jiménez Díaz, Madrid, Spain.
H KutznerDermatopathologie Friedrichshafen, Friedrichshafen, Germany.
Luis RequenaDepartment of Dermatology, Fundación Jiménez Díaz, Madrid, Spain.
Miguel A PirisDepartment of Pathology, Fundación Jiménez Díaz, Madrid, Spain.ORCID 0000-0001-8179-9739
Hospital Universitario Fundación Jiménez Díaz · ESUniversidade da Coruña · ESDermatopathologie Friedrichshafen · DEMarqués de Valdecilla University Hospital · ESUniversidad de Cantabria · ESUniversidad Rey Juan Carlos · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsMerkel cell carcinoma (MCC) is an aggressive primary neuroendocrine tumor of the skin, associated with Merkel cell polyomavirus (MCPyV) in 49-89% of cases, depending on the country of origin and the techniques of detection. The presence of MCPyV defines heterogeneity in MCC; MCPyV-negative cases bear a much higher mutational load, with a distinct ultraviolet signature pattern featuring C > T transitions, as a consequence of exposure to ultraviolet light radiation. MCC stroma has not been thoroughly studied, although MCC patients benefit from therapy targeting PD1/PDL1. METHODS AND

resultsIn this study, using Tissue Microarrays and immunohistochemistry, we have analyzed a series of 219 MCC cases in relation to the presence of MCPyV, and confirmed that the presence of MCPyV is associated with changes not only in the neoplastic cells, but also in the composition of the tumor stroma. Thus, MCPyV, found in 101/176 (57,4%) analyzable cases, exhibits changes in its tumor morphology, the density of the inflammatory infiltrate, the phenotype of the neoplastic cells, and the cell composition of the tumor stroma. MCPyV presence is negatively correlated with a higher level of p53 expression, and associated with a very high frequency (86%) of HLA-I expression loss, a higher apoptotic index, and a stroma richer in T-cells, cytotoxic T-cells, macrophages, PDL1-positive macrophages, and B-cells.

conclusionsOur findings provide evidence of the basic heterogeneity of MCC, supporting the hypothesis that the presence of MCPyV may induce a rich inflammatory response, which is at least partially avoided through loss of HLA-I antigen expression. On the other hand, MCPyV-negative cases show a much higher frequency of stronger p53 expression and, probably, p53 alterations.

Indexed as

PhenotypeTumor MicroenvironmentAgedAged, 80 and overCarcinoma, Merkel CellFemaleHumansMaleMerkel cell polyomavirusMiddle Aged

Identifiers

PMID32687503
PMCPMC7371188
OpenAlexW3045136496

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.